2002
“Constitutional Limitations on FDA Regulation of Promotion” at the Federalist Society
This event has already occurred.
Related Insights
Fintechs, Novel Charters, and Fed Master Accounts—Of Elephants and Mouseholes
Fintechs, Novel Charters, and Fed Master Accounts—Of Elephants and Mouseholes
April 24, 2024
6min
Alvotech and Teva’s Selarsdi™ (ustekinumab-aekn), Biosimilar to Stelara® Approved by FDA
Alvotech and Teva’s Selarsdi™ (ustekinumab-aekn), Biosimilar to Stelara® Approved by FDA
April 23, 2024
2min
DOJ Announces Pilot Program for Individual Voluntary Self-Disclosures
DOJ Announces Pilot Program for Individual Voluntary Self-Disclosures
April 22, 2024
5min
Events
AI in Pharma: Transforming Life Sciences IP and Reshaping the Hatch-Waxman Litigation Landscape
AI in Pharma: Transforming Life Sciences IP and Reshaping the Hatch-Waxman Litigation Landscape
April 25 - 26, 2024 New York, NY - American Conference Institute
Potential Advertising Pitfalls for Consumer Financial Product and Service Providers
Potential Advertising Pitfalls for Consumer Financial Product and Service Providers
April 25, 2024 Washington, DC - Venable
Consumer Financial Services Legal and Regulatory Update at the FCAA 2024 Annual Conference
Consumer Financial Services Legal and Regulatory Update at the FCAA 2024 Annual Conference
May 01 - 03, 2024 New Orleans, LA - Financial Counseling Association of America (FCAA)